Loading company details...
Beta
Latest Form 4 (Oct 6, 2026): Matthew Bowen (Principal Accounting Officer): Sale of 13 shares, $137.28.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Matthew Bowen, Principal Accounting Officer | Sale | 13 | $137.28 |
| Jul 17, 2026 | Markus Warmuth, President & CEO | Sale | 9,500 | $220.2K |
| Jul 16, 2026 | Jennifer Champoux, Chief Operating Officer | Exercise/Conversion | 4,351 | $17.3K |
| Jul 7, 2026 | Sharon Townson, Chief Scientific Officer | Exercise/Conversion | 6,000 | $36.8K |
| Jul 6, 2026 | Ali Behbahani | Other (see footnotes) | 1,000,000 | n/a |
| Jul 1, 2026 | Filip Janku, Chief Medical Officer | Exercise/Conversion | 5,407 | $72.5K |
| Jun 30, 2026 | Filip Janku, Chief Medical Officer | Exercise/Conversion | 6,000 | $45.4K |
| Jun 30, 2026 | Anthony M. Manning | Exercise/Conversion | 10,000 | $41.6K |
| Jun 25, 2026 | Filip Janku, Chief Medical Officer | Exercise/Conversion | 6,000 | $45.4K |
| Jun 25, 2026 | Jennifer Champoux, Chief Operating Officer | Exercise/Conversion | 2,175 | $8.7K |